SEROQUEL

Swiss trademark · 365953 · Word mark · In force

Register entry

Registration number
365953
Application number
01742/1988
Status
In force
Type
Word mark
Filed
Mar 10, 1988
Registered
Dec 15, 1988
Published
Jan 24, 1989
Protected until
Mar 10, 2028
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate und Substanzen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 9, 2026

    Agent’s address changed

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 09.10.2026

  2. Mar 17, 2023

    Agent removed

    Representative
    Dennemeyer AG, Bahnhofstrasse 23, 6300 Zug (removed)

    Published in Swissreg on 17.03.2023

  3. Mar 17, 2023

    Transferred

    Owner
    AstraZeneca UK Limited, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, United Kingdom → Cheplapharm Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Germany
    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 17.03.2023

  4. Jul 9, 2019

    Agent’s address changed

    Representative
    Dennemeyer AG, Bahnhofstrasse 23, P.O. Box 831, 6301 Zug → Dennemeyer AG, Bahnhofstrasse 23, 6300 Zug

    Published in Swissreg on 09.07.2019

  5. Feb 19, 2018

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel → Dennemeyer AG, Bahnhofstrasse 23, P.O. Box 831, 6301 Zug

    Published in Swissreg on 19.02.2018

  6. Feb 19, 2018

    Renewed

    Published in Swissreg on 19.02.2018

  7. Feb 7, 2018

    Holder’s address changed

    Owner
    AstraZeneca UK Limited, 15 Stanhope Gate, London W1Y 6LN, United Kingdom → AstraZeneca UK Limited, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, United Kingdom

    Published in Swissreg on 07.02.2018

  8. Jul 8, 2014

    Agent’s address changed

    Representative
    BOHEST AG, Postfach 160, 4003 Basel → BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 08.07.2014

5 earlier entries
  1. May 5, 2008

    Agent’s address changed

    Representative
    A. Braun Braun Héritier Eschmann AG, Patentanwälte VSP, Holbeinstrasse 36-38, Postfach 160, 4003 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in the SOGC no. 85 of 05.05.2008

  2. Mar 3, 2008

    Renewed

    Published in the SOGC no. 43 of 03.03.2008

  3. Jul 22, 2002

    Transferred

    Owner
    Zeneca Limited, Imperial Chemical House, 9, Millbank, GB- London SW1P 3JF, United Kingdom → AstraZeneca UK Limited, 15 Stanhope Gate, London W1Y 6LN, United Kingdom
    Representative
    A. Braun, Braun, Héritier,, Eschmann AG,, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → A. Braun Braun Héritier Eschmann AG, Patentanwälte VSP, Holbeinstrasse 36-38, Postfach 160, 4003 Basel

    Published in the SOGC no. 139 of 22.07.2002

  4. Mar 8, 1994

    Transferred

    Owner
    Imperial Chemical Industries PLC, Imperial Chemical House, Millbank, GB- London SW 1, United Kingdom → Zeneca Limited, Imperial Chemical House, 9, Millbank, GB- London SW1P 3JF, United Kingdom

    Published in the SOGC no. 47 of 08.03.1994

  5. Jan 24, 1989

    Registered

    Published in the SOGC no. 16 of 24.01.1989

Parties

Holder

Cheplapharm Arzneimittel GmbH

Ziegelhof 24, 17489 Greifswald, DE

Agent

Dr. Lusuardi AG

Stockerstrasse 8, 8002 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.